Boston Scientific signs deal with BG Medicine to use heart diagnostic test

03/31/2011 | MassDevice.com (Boston)

BG Medicine has entered an agreement with Boston Scientific allowing the latter to use its galectin-3 test for heart failure to pinpoint patients who might be candidates for a cardiac resynchronization treatment. The deal will allow Boston Scientific to use BG's biomarker discovery technologies to identify other biomarkers that could help predict patients' responses to the therapy.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN